Pharmaceutical

FDA approves Astellas’ VYLOY for gastric cancer treatment

Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced gastric cancer.

Oct 22, 2024 - 04:00
FDA approves Astellas’ VYLOY for gastric cancer treatment
Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced gastric cancer.
Read the original article

Tags:

Previous Article

FDA clamps partial hold on Phase III trial of BioNTech & OncoC4’s NSCLC therapy

Next Article

Novartis strikes $1.1B deal with China’s Baiyu for a small molecule cancer conte...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: CVS wants to become a medical powerhouse. Will long lines and understaffing hold it back?

STAT+: CVS wants to become a medical powerhouse. Will l...

Jan 26, 2024

EMA’s CHMP recommends Bristol Myers Squibb’s Breyanzi approval

EMA’s CHMP recommends Bristol Myers Squibb’s Breyanzi a...

Apr 3, 2023

New Senate deal would ban some facility fees, reform hospital contracting

New Senate deal would ban some facility fees, reform ho...

Sep 14, 2023